Lupuzor - Orion, the final step before regulatory approval. Patient recruitment is anticipated to occur in up to 45 investigator sites, 10 in the United States and 35 in Europe. In the US the first patient dosing commenced in February 2016. In Europe, the first sites have opened in France and patient recruitment has commenced. The trial progress can be tracked on the www.ClinicalTrials.gov/lupuzor website and the key milestone for this year is for the recruitment of the 200 Lupus patients, wi
11 May 2016
Recruitment underway to enrol 200 patients in the pivotal Phase III clinical trial for Lupuzor
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Recruitment underway to enrol 200 patients in the pivotal Phase III clinical trial for Lupuzor
ImmuPharma plc (IMM:LON) | 2.2 0 0.5% | Mkt Cap: 9.12m
- Published:
11 May 2016 -
Author:
Capital Access Team -
Pages:
9
Lupuzor - Orion, the final step before regulatory approval. Patient recruitment is anticipated to occur in up to 45 investigator sites, 10 in the United States and 35 in Europe. In the US the first patient dosing commenced in February 2016. In Europe, the first sites have opened in France and patient recruitment has commenced. The trial progress can be tracked on the www.ClinicalTrials.gov/lupuzor website and the key milestone for this year is for the recruitment of the 200 Lupus patients, wi